The Future of Infection Prevention and Control Conference 2017

HSP will be attending “The Future of Infection Prevention and Control Conference 2017″  in Salford on Tuesday, 28th March 2017. Drop by stand 6 to have a chat about our latest products and solutions.


The Infection Prevention and Control Conference boasts a variety of outstanding speakers from the across the health care sector. Each one has been handpicked based on their experience and professional background to ensure that all delegates benefit from relevant, high-quality presentations.  Expect  speakers  to cover a wide variety of topics including:

Reducing acquired infections: Steps taken over the last year have helped reduce the number of health care acquired infections (HCAIs) in the NHS with instances of some strains falling by up to 42%. Despite ever more rigorous infection prevention measures, NHS England recorded 1,477  MRSA  bloodstream  infections among hospital patients in 2015/16. Estimates by the National Institute of Health and Care Excellence suggest that up 300,000 patients a year acquire some form of infection as a result of NHS care in England. These infections can slow patient recovery, increase the length  of  hospital  stays and cost the NHS millions of pounds a year. How can NHS leaders build on progress made in the last decade, continue to drive improvement and move towards a zero tolerance approach to HCAIs?

Post-antibiotic era: Discussing his Antimicrobial Resistance Review, Lord Jim O’Neill said: “The problem of drug-resistant infections could be compared to a slow-motion car crash – one that has sadly already begun. 700,000 people are already dying every year from resistant  infections,  rising  to 10 million a year by 2050.” In September 2016, the G20 announced measures to tackle the rise of superbugs by investing in antibiotic research and development. While the UK has lead the way in terms of controlling and reducing the use of antibiotics, there is still significant  work  to  be done. The Royal College of General Practitioners has urged members to monitor the number of antibiotics being prescribed. Rose Gallagher of the Royal College of Nursing has argued that nurses and midwives are uniquely positioned to lead the next stages of the response to antibiotic resistance.  What  role  do different NHS professionals have to play when it comes to reducing the use of antibiotics and preventing the spread of drug resistant infections?

Community based care: A key element of the NHS Five Year Forward view is the move towards a more community centred model of care. Aside from the benefits of freeing up beds and reducing costs, keeping patients out of hospital is one of the most effective ways of preventing and controlling  the  spread  of infection. How will treating more patients closer to home impact on infection prevention and what new challenges will this pose?

The latest innovations: With existing antibiotics and traditional methods for controlling infections failing, the need to innovate is ever more crucial. New technologies such UV automated disinfection systems are driving up hygiene standards while advances in biotech to produce “predatory  bacteria”  are  showing early signs of promise. What are the latest developments in the fight against superbugs and how will they shape the future of infection prevention and control?